Robert I Garver

This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, Uab Research Center. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert I Garver. Retrieved from https://idiyas.com/inventor/robert-i-garver

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 49(Granted Patents)

Company Filing History:

1 out of 3,801

Johns Hopkins University

where one patent can have more than one assignee

Years Active: 2005

Loading Chart...

1 patent (USPTO):Sort by Forward CitationsExplore Patents

1. 6916490 - Controlled release of bioactive substances (2005-07-12),

Title: The Innovations of Robert I Garver

Introduction

Robert I Garver is an accomplished inventor based in Hoover, Alabama. He has made significant contributions to the field of bioactive substances, particularly in the area of controlled release mechanisms. His work has implications for various applications, including medical and pharmaceutical advancements.

Latest Patents

Garver holds a patent for the "Controlled release of bioactive substances." This invention involves coacervates that encapsulate a bioactive substance and a delivery agent for controlled release. In certain embodiments, the bioactive substance is a viral vector, while the delivery agent is a virus. The patent describes processes for preparing and utilizing these coacervates effectively.

Career Highlights

Throughout his career, Garver has worked with notable institutions such as the UAB Research Center and The Johns Hopkins University. His experience in these prestigious organizations has allowed him to collaborate with leading experts in his field and contribute to groundbreaking research.

Collaborations

Some of Garver's notable coworkers include Subramanian Kalyanasundaram and Kam W Leong. Their collaborative efforts have further advanced the research and development of innovative solutions in bioactive substance delivery.

Conclusion

Robert I Garver's contributions to the field of controlled release of bioactive substances highlight his innovative spirit and dedication to advancing science. His patent and collaborations reflect a commitment to improving medical and pharmaceutical technologies.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]